Related Experiment Videos

Adjunctive thrombolytic agents with coronary interventional techniques

S J Yakubov1, B S George, A T Chapekis

  • 1Mid West Cardiology Research Foundation, Riverside Methodist Hospital, Columbus, Ohio.

Cardiology Clinics
|November 1, 1994
PubMed

Insights

Thrombolytics are crucial for interventional procedures like PTCA and stenting. This review explores their diverse applications and summarizes key clinical trial findings regarding their use in cardiovascular interventions.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Pharmacology

Background:

  • Thrombolytic agents are utilized in various interventional cardiovascular procedures.
  • Current applications include direct lytic therapy and adjunctive use with percutaneous transluminal coronary angioplasty (PTCA), directional atherectomy, and intracoronary stenting.
  • Controversy exists regarding optimal thrombolytic dosage and agent selection.

Purpose of the Study:

  • To comprehensively review the potential applications of thrombolytic therapy in interventional cardiology.
  • To synthesize findings from major clinical trials investigating thrombolytic use in these contexts.

Main Methods:

  • Literature review of interventional cardiology procedures involving thrombolytics.
  • Analysis of data from significant clinical trials on thrombolytic efficacy and safety.

Main Results:

  • Thrombolytics demonstrate utility across a spectrum of interventional cardiovascular treatments.
  • Evidence from major trials provides insights into the effectiveness and controversies surrounding thrombolytic dosage and choice.

Conclusions:

  • Thrombolytic therapy remains an important component of interventional cardiovascular medicine.
  • Further research and consensus are needed to standardize thrombolytic protocols for optimal patient outcomes.

Related Concept Videos